デフォルト表紙
市場調査レポート
商品コード
1323012

経鼻ドラッグデリバリー技術の世界市場

Nasal Drug Delivery Technology

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
経鼻ドラッグデリバリー技術の世界市場
出版日: 2023年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

経鼻ドラッグデリバリー技術の世界市場は2030年までに1,119億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に748億米ドルと推計された経鼻ドラッグデリバリー技術の世界市場は、2030年には1,119億米ドルに達すると予測され、2022年から2030年にかけてCAGR 5.2%で成長すると予測されます。本レポートで分析したセグメントの一つである鼻腔スプレーは、CAGR 5.8%を記録し、分析期間終了時には605億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、ドロップス&リキッド分野の成長は今後8年間のCAGRを4.6%に修正しました。

米国市場は224億米ドル、中国はCAGR 4.8%で成長すると予測

米国の経鼻ドラッグデリバリー技術市場は、2022年には224億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 4.8%で推移し、2030年までに予測市場規模は195億米ドルに達すると予測されます。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ5.1%と4%の成長が予測されています。欧州では、ドイツがCAGR約4.2%で成長すると予測されています。

調査対象企業の例

  • 3M Company
  • Aegis Therapeutics LLC
  • Aptargroup, Inc.
  • AstraZeneca PLC
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP13533

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nasal Drug Delivery Technology Market to Reach $111.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nasal Drug Delivery Technology estimated at US$74.8 Billion in the year 2022, is projected to reach a revised size of US$111.9 Billion by 2030, growing at aCAGR of 5.2% over the period 2022-2030. Nasal Sprays, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$60.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drops & Liquids segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $22.4 Billion, While China is Forecast to Grow at 4.8% CAGR

The Nasal Drug Delivery Technology market in the U.S. is estimated at US$22.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.5 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 47 Featured) -

  • 3M Company
  • Aegis Therapeutics LLC
  • Aptargroup, Inc.
  • AstraZeneca PLC
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Nasal Drug Delivery Technology - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nasal Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Drops & Liquids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Multi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Unit-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Bi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Allergic & Non-allergic Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Nose Congestion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Nasal Drug Delivery Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • JAPAN
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • CHINA
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: China 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: China 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • EUROPE
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • FRANCE
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: France 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: France 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: France 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: France 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • GERMANY
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Rest of Europe 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Asia-Pacific 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 176: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of World Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of World 16-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of World 16-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of World 16-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2014, 2023 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of World 16-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2014, 2023 & 2030

IV. COMPETITION